dbacp05820
General Description
Peptide name : R8
Source/Organism : Not found
Linear/Cyclic : Not found
Chirality : Not found
Sequence Information
Sequence : CALRRRRRRRR
Peptide length: 11
C-terminal modification: Not found
N-terminal modification : Not found
Non-natural peptide information: None
Activity Information
Assay type : SPR assay
Assay time : Not found
Activity : Not found
Cell line : B16
Cancer type : Mouse Melanoma
Other activity : Not found
Physicochemical Properties
Amino acid composition bar chart :
Molecular mass : 1554.8793 Dalton
Aliphatic index : 0.445
Instability index : 391.109
Hydrophobicity (GRAVY) : -2.536
Isoelectric point : 12
Charge (pH 7) : 7.7501
Aromaticity : 0
Molar extinction coefficient (cysteine, cystine): (0, 0)
Hydrophobic/hydrophilic ratio : 0.375
hydrophobic moment : -0.243
Missing amino acid : W,T,P,I,M,E,K,F,D,N,G,H,Q,S,Y,V
Most occurring amino acid : R
Most occurring amino acid frequency : 8
Least occurring amino acid : C
Least occurring amino acid frequency : 1
Structural Information
3D structure :
Secondary structure fraction (Helix, Turn, Sheet): (0.1, 0, 0.0)
SMILES Notation: CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
Secondary Structure :
| Method | Prediction |
|---|---|
| GOR | HHHHHHHHHTT |
| Chou-Fasman (CF) | HHHHHHHHCCC |
| Neural Network (NN) | HHHHHHHCCCC |
| Joint/Consensus | HHHHHHHHCCC |
Molecular Descriptors and ADMET Properties
Molecular Descriptors: Click here to download
ADMET Properties: Click here to download
Cross Referencing databases
CancerPPD : Not available
ApIAPDB : Not available
CancerPPD2 ID : Not available
Reference
1 : He B, et al. Increased cellular uptake of peptide-modified PEGylated gold nanoparticles. Biochem Biophys Res Commun. 2017; 494:339-345. doi: 10.1016/j.bbrc.2017.10.026
Literature
Paper title : Increased cellular uptake of peptide-modified PEGylated gold nanoparticles.
Doi : https://doi.org/10.1016/j.bbrc.2017.10.026
Abstract : Gold nanoparticles are promising drug delivery vehicles for nucleic acids, small molecules, and proteins, allowing various modifications on the particle surface. However, the instability and low bioavailability of gold nanoparticles compromise their clinical application. Here, we functionalized gold nanoparticles with CPP fragments (CALNNPFVYLI, CALRRRRRRRR) through sulfhydryl PEG to increase their stability and bioavailability. The resulting gold nanoparticles were characterized with transmission electron microscopy (TEM), dynamic light scattering (DLS), UV-visible spectrometry and X-ray photoelectron spectroscopy (XPS), and the stability in biological solutions was evaluated. Comparing to PEGylated gold nanoparticles, CPP (CALNNPFVYLI, CALRRRRRRRR)-modified gold nanoparticles showed 46 folds increase in cellular uptake in A549 and B16 cell lines, as evidenced by the inductively coupled plasma atomic emission spectroscopy (ICP-AES). The interactions between gold nanoparticles and liposomes indicated CPP-modified gold nanoparticles bind to cell membrane more effectively than PEGylated gold nanoparticles. Surface plasmon resonance (SPR) was used to measure interactions between nanoparticles and the membrane. TEM and uptake inhibitor experiments indicated that the cellular entry of gold nanoparticles was mediated by clathrin and macropinocytosis. Other energy independent endocytosis pathways were also identified. Our work revealed a new strategy to modify gold nanoparticles with CPP and illustrated the cellular uptake pathway of CPP-modified gold nanoparticles.